AMGN vs PLUS · P/E 24, rev $36.75B vs P/E 17, rev $2.07B
Amgen Inc (AMGN) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the AMGN and PLUS stock pages for the full models.
Not investment advice.